Resources
For the latest in biomarkers & precision medicine, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Omics/Sapient%20Webinar%20Website%20Featured%20Image.jpg)
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/R%26D%20Top%20Stories%20eBook%20Content%20Portal%20Image.png)
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/AdobeStock_333938100-scaled.jpg)
Clinical Development
The Patient-focused ‘Paradigm Shift’ That Could ‘Revolutionise’ Clinical Trials
Melanie Anderson, Principal Scientist at MSD, on how the pandemic has made scientists rethink clinical trials.
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/Discussion-Group-Implementing-Flow-Cytometry-Assays.jpg)
Biomarker Discovery & Development
Implementing Flow Cytometry Assays In Biomarker Research
Oxford Global’s Discussion Groups provide a focused networking opportunity for a select group of like-minded experts on a monthly basis. Our first Biomarkers Discussion Group addressing ‘Implementing Flow Cytometry Assays In Biomarker Research’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/digital-biomarkers-1-scaled.jpg)
Digital Biomarkers
Digital Biomarkers – An Industry Game Changer
This commentary article looks at the latest applications in digital and wearable biomarkers, with industry and academic insights from GlaxoSmithKline, Roche, and University College London.
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/AdobeStock_391207493-scaled.jpg)
Digital Biomarkers
Overcoming the Regulatory Challenges of Digital Health Technologies
Dr Derek Hill, Professor of Digital Health at University College London, on making the most of digital biomarkers and achieving clinical endpoints.
![](https://oxfordglobal.com/hubfs/Website/Images/Resources/Biomarkers/Industry-Insight-from-Owlstone-Medical.jpg)
Diagnostic Development
Non-invasive Early Disease Detection and Precision Medicine Using Breath Biomarkers
Breath is the ideal biomarker matrix for the future of diagnostics. Sample collection is non-invasive, painless and easy to perform, and breath is a rich source of potential biomarkers. Potential applications for breath tests include disease detection, phenotyping, progression and treatment monitoring, and complementary diagnostics. Discover the benefits and capabilities of breath testing, and start researching breath biomarkers with Breath Biopsy®.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biomarkers